News

Monster Beverage (MNST) delivered earnings and revenue surprises of +1.70% and +4.97%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Innodata Inc (INOD) delivered earnings and revenue surprises of +95.24% and +6.75%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

ICF (ICFI) delivered earnings and revenue surprises of +10.06% and -0.36%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

ARK Makes Bold $23 Million SpaceX Bet Despite Post-Earnings Drop

The headline numbers for Airbnb (ABNB) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Although the revenue and EPS for Halozyme Therapeutics (HALO) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Moby summary of Celsius Holdings, Inc.'s Q2 2026 earnings call

Halozyme Therapeutics (HALO) delivered earnings and revenue surprises of +25.28% and +17.44%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Airbnb (ABNB) delivered earnings and revenue surprises of +14.17% and +0.81%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Axon Enterprise (AXON) lifted its 2026 revenue growth outlook to a range of 32% to 34% after reporting Q2 results that exceeded sales estimates but came with margin pressure and an earnings per share miss versus expectations. See our latest analysis for Axon Enterprise. The raised 2026 guidance comes after a sharp rebound in Axon Enterprise’s share price, with a 7 day share price return of 14.74% and a 90 day share price return of 42.77%. That pace contrasts with a 1 year total shareholder...

MARA’s bitcoin holdings drove a $611 million quarterly loss, while new sites and bitcoin-backed borrowing advanced its planned expansion into AI infrastructure.

Symbotic Inc. recently reported third-quarter 2026 results, with revenue rising to US$720.84 million and net income reaching US$11.67 million, alongside the appointment of former Bain Capital Co‑Chair Steve Pagliuca to its Board and new fourth‑quarter revenue guidance of US$760 million to US$780 million. The company’s return to profitability over both the quarter and the nine‑month period, coupled with revenue guidance that points to continued operational momentum, could be especially...

Moby summary of Townsquare Media, Inc.'s Q2 2026 earnings call

Moby summary of Bentley Systems, Incorporated's Q2 2026 earnings call

Redwire is making progress, but remains a speculative investment.

Collaboration software company Atlassian (NASDAQ:TEAM) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 27.6% year on year to $1.77 billion. Guidance for next quarter’s revenue was optimistic at $1.71 billion at the midpoint, 2.8% above analysts’ estimates. Its non-GAAP profit of $1.87 per share was 24.5% above analysts’ consensus estimates.

The Trade Desk (TTD) delivered earnings and revenue surprises of -17.07% and -4.86%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Moby summary of Cars.com Inc.'s Q2 2026 earnings call

Moby summary of LifeStance Health Group, Inc.'s Q2 2026 earnings call

MACOM Technology Solutions (NASDAQ:MTSI) reported record fiscal third-quarter results, citing strong demand across its data center, industrial and defense, and telecom markets. The company also issued fourth-quarter guidance that calls for another sequential increase in revenue, margins and adjusted

Lexicon Pharmaceuticals (NASDAQ:LXRX) reported a wider second-quarter loss as revenue declined sharply from the prior-year period, while the company highlighted completed enrollment in its Phase III SONATA-HCM trial and outlined plans to resubmit a new drug application for ZYNQUISTA in type 1 diabet

MKS (NASDAQ:MKSI) reported second-quarter 2026 revenue of $1.25 billion, up 16% sequentially and 28% from a year earlier, as demand increased across semiconductor, electronics and packaging, and specialty industrial markets. Management said revenue and key profitability measures reached the high end

Lightbridge (NASDAQ:LTBR) reported progress in its nuclear fuel development program during the second quarter and first half of 2026, including the removal of its first irradiated fuel material samples from Idaho National Laboratory’s Advanced Test Reactor and steps toward commercial-scale fabricati

Ligand Pharmaceuticals (NASDAQ:LGND) reported second-quarter 2026 results marked by higher royalty revenue and adjusted earnings, while highlighting the post-quarter close of its XOMA Royalty acquisition and a $700 million zero-coupon convertible-note offering. Total revenue rose 34% year over year

Moby summary of Targa Resources Corp.'s Q2 2026 earnings call

Moby summary of Arhaus, Inc.'s Q2 2026 earnings call

Digital advertising platform The Trade Desk (NASDAQ:TTD) fell short of the market’s revenue expectations in Q2 CY2026 as sales rose 3% year on year to $715.1 million. Next quarter’s revenue guidance of $650 million underwhelmed, coming in 19.2% below analysts’ estimates. Its non-GAAP profit of $0.34 per share was 15.1% below analysts’ consensus estimates.

Airbnb stock leaped late Thursday after the online vacation rental platform posted second-quarter results ahead of estimates and offered a strong forecast for the September quarter. Airbnb earned $1.37 per share for the June-ended quarter, up 33% from a year earlier. The gross value of bookings on Airbnb's platform increased 16% to $27.2 billion.

Sports betting and online gaming company DraftKings Inc (NASDAQ:DKNG) reported second-quarter financial results Thursday after market close. Here are the key highlights. • DraftKings stock is facing resistance. Why is DKNG stock trading lower? DraftKings Q2 Earnings DraftKings reported second-quarter...

Biopharmaceutical drug delivery company Halozyme Therapeutics (NASDAQ:HALO) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 47.7% year on year to $481 million. The company’s full-year revenue guidance of $1.87 billion at the midpoint came in 5.9% above analysts’ estimates. Its non-GAAP profit of $2.28 per share was 25.5% above analysts’ consensus estimates.